PG4

BIOLOGICAL5 trials

Sponsors

Pfizer

Conditions

Pneumococcal Disease

Phase 2

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

Active, not recruitingNCT06524414

PfizerPneumococcal Disease

Start: 2024-07-25End: 2027-05-01Updated: 2026-09-03

A Study to Learn About How a New Pneumococcal Vaccine Works in Children

CompletedNCT06531538

PfizerPneumococcal Disease

Start: 2024-07-30End: 2026-02-09Updated: 2026-03-11

Phase 3

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

RecruitingNCT07573462

PfizerPneumococcal Disease

Start: 2026-05-04End: 2028-12-30Target: 2400Updated: 2026-09-15

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

RecruitingNCT07629440

PfizerPneumococcal Disease

Start: 2026-05-29End: 2029-06-05Target: 3230Updated: 2026-09-08

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

RecruitingNCT07660198

PfizerPneumococcal Disease

Start: 2026-06-15End: 2027-12-02Target: 1200Updated: 2026-08-31